跳至主要内容
临床试验/NCT04085120
NCT04085120Unknown不适用

Comparison Between Ropivacaine/Dexamethasone and 10% Lignocaine Injection in Distal Glossopharyngeal Nerve Block for Intractable Cancer Pain- A Randomized Trial

All India Institute of Medical Sciences, New Delhi2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年8月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
Pain reduction on the basis of the Numeric rating scale (NRS).

研究概览

简要总结

The study will compare the efficacy and safety of Ropivacaine/dexamethasone vs 10% lignocaine injection in distal glossopharyngeal nerve block for intractable cancer pain

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with proven carcinoma of the oropharynx and supraglottic larynx with estimated survival of 3 months or more.
  • Pain lasting for at least 2 weeks with an average intensity of 5 or more on an 11-point numeric rating scale (NRS) refractory to a combination strong opioids and NSAIDS

排除标准

  • Local infection or skin ulceration at the puncture site
  • Local anaesthetic allergy
  • Psychiatric illness that affected cooperation.

研究组 & 干预措施

Ropivacaine/dexamethasone group

Experimental

3ml of 0.75% ropivacaine and 1ml of 4mg/l dexamethasone will be injected.

干预措施: 0.75 % Ropivacaine/ 4mg/mL dexamethasone injection (Procedure)

10% lignocaine injection group

Experimental

4 ml of 10% lignocaine

干预措施: 10% lignocaine injection (Procedure)

结局指标

主要结局

Pain reduction on the basis of the Numeric rating scale (NRS).

时间窗: 4 weeks

Pain reduction on the basis of the Numeric rating scale (NRS). From 0 to 10 (No pain to highest pain)

次要结局

  • Brief Pain Inventory (BPI)- short form(4 weeks)
  • Clinical Global Impression of Change (CGIC)(4 weeks)
  • Analgesic requirement and rescue analgesic requirement(4 weeks)
  • Patient Global Impression of Change (PGIC)(4 weeeks)
  • WHO Quality of Life-BREF(4 weeks)

研究者

发起方
All India Institute of Medical Sciences, New Delhi
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr.Dinesh Manoharan

Senior Resident

All India Institute of Medical Sciences, New Delhi

研究点 (2)

Loading locations...

相似试验